REFERENCE
Ko Y, Malone DC, Armstrong EP.Pharmacoeconomic evaluation of antimuscarinic agents for the treatment of overactive bladder. Pharmacotherapy 26: 1694-1702, No. 12, Dec 2006
Rights and permissions
About this article
Cite this article
Solifenacin economically dominant in OAB. Pharmacoecon. Outcomes News 521, 1 (2007). https://doi.org/10.2165/00151234-200705210-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200705210-00001